Several studies have shown that NAMPT and NAD+ are frequently upregulated in several human malignancies and play key roles in the development, progression, and recurrence of cancer (Lucena-Cacace et al, 2018; Zhang et al, 2019). This evidence concerns the gene NAMPT and cancer.